Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19

Overview of attention for article published in Frontiers in Molecular Biosciences, August 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 4 X users

patent: 2 patents

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 9,044 followers.

Frontiers | Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19 | Molecular Biosciences https://t.co/BiHWq8wVsG

11 Dec 2020

Reply Repost Favourite

August 7, 2020 "Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19" by Navin Kumar Verma, Mobashar Hussain Urf Turabe Fazil, et al: https://t.co/an9G8B3RyU #rhACE2

09 Aug 2020

Reply Repost Favourite

New Research: Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19 https://t.co/ABseCXfPqS #MolBioSci